The World Health Organization announced it will resume a clinical trial evaluating the efficacy of hydroxychloroquine for COVID-19 patients after the organization halted it following studies showing higher risks to patients taking the drug.

Former FDA Commissioner Scott Gottlieb expects a vaccine for the new coronavirus, COVID-19, will be seasonal, akin to a flu shot.

CMS is increasing enforcement, including civil penalties, against nursing homes with persistent infection control violations for COVID-19. 

The Lancet has issued four corrections to a research paper that found COVID-19 patients who used the drug hydroxychloroquine have a higher risk of death.

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Disease (NIAID) and White House public health advisor, is concerned that a potential vaccine to protect against the novel coronavirus, COVID-19, may not deliver long-term immunity.

A group consisting of 140 scientists and physicians has spoken out against a study published in The Lancet that found an association between the use of the drug hydroxychloroquine and a higher death rate among COVID-19 patients.

Just 7 in 10 Americans said they would get a vaccine to protect against COVID-19, according to an ABC News/Washington Post poll, with 15% of adults saying they definitely and 12% saying they probably would not get the vaccine.

Healthcare providers are still asking the Trump administration for help securing personal protective equipment (PPE) as they continue to care for COVID-19 patients.

Jerome Labat has been hired as Cerner Corporation’s new chief technology officer.

President Trump has stated he wants to terminate the United States’ relationship with the World Health Organization.

Cancer patients also diagnosed with COVID-19 are much more likely to die compared to the general public, according to a new study published in The Lancet.

CVS Health has been accused of overcharging for generic medications in a new lawsuit brought forth by six Blue Cross Blue Shield plans.